MacroGenics, Inc.
COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF
Last updated:
Abstract:
The disclosure relates to compounds specific for IL23A and BAFF, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2020
Issue date:
15 Apr 2021